StaveMD logo

StaveMD Review

7.1
★★★★☆3.6/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10

Best for: people who want semaglutide, tirzepatide, an oral tablet or a microdose from one brand, billed monthly

StaveMD scores highest on the strength of its clinical program: drug options and dosing support.

Semaglutide

$149per 4 weeks

Tirzepatide

$199per 4 weeks

Price checked on StaveMD’s site,

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

StaveMD is a telehealth brand that prescribes compounded semaglutide (injection or dissolving tablet), tirzepatide and low-dose microdose programs through OpenLoop's clinician network, with named compounding pharmacies and free shipping. Month-to-month plans start at $149 for semaglutide and $199 for tirzepatide. The "from $109/mo" headline is the 52-week plan, charged as $1,417 upfront.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideOral OptionMicrodose OptionsFree ShippingHSA/FSA EligibleNamed Pharmacies

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to StaveMD

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
StaveMD logo
3.6 / 5
Our editorial rating
Visit StaveMD →

from $149/4 wks (billed per 4 weeks) · no insurance needed

StaveMD at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$149/4 wks (billed per 4 weeks) (12 weeks $417, 24 weeks $774, 52 weeks $1,417 upfront (the "$109/mo" headline))
What's included
Medication · Consult · Shipping
FDA status
No FDA warning letter on record

How we scored StaveMD

Each dimension is scored algorithmically from StaveMD’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

7.7/10

At $149/mo (per 4 weeks), StaveMD runs about 17% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).

Effectiveness25%

7.8/10

StaveMD offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

7.0/10

Online intake and platform experience (consult included in the price); 8 platform features disclosed.

Trust & Safety15%

6.9/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

6.1/10

StaveMD's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.

Support10%

5.5/10

StaveMD provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this StaveMD review

Last checked September 2026
  • Confirmed current pricing across 5 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$149–$199/mo across 5 dose/plan tiers (checked September 2026)
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with StaveMD

We walked StaveMD’s public signup flow in September 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Pick a program on the homepage (semaglutide injection, oral semaglutide, tirzepatide or microdose) and click "Get started"
  2. 2An intake of about 25 screens covers height and weight, goal weight, sex, pregnancy, goals, sleep, medical history, contraindications, blood pressure, heart rate, medications and allergies
  3. 3A summary screen shows your BMI and a projected weight-loss timeline
  4. 4Enter date of birth, shipping address, name, phone and email, and accept the telehealth consent
  5. 5Choose a treatment, then a 4, 12, 24 or 52-week plan on the order review screen, before checkout and payment
Price shown only after intake
  • The homepage shows only "starting at" figures, and each one is the 52-week prepaid tier rather than a monthly bill
  • The month-to-month price and every prepaid total appear only on the order review, after the full intake and your contact details
  • The order review labels prices "/mo" beside a "4 week plan," so a year is 13 charges
  • The checkout authorization names OpenLoop Health, Inc as the company that charges your card
  • The intake screens for the recognized GLP-1 contraindications, including pregnancy, pancreatitis, medullary thyroid cancer and MEN2
  • The microdose program asks you to agree to get weight-loss medication only through this platform

StaveMD customer support

Email
hello@stavemd.com

GLP-1 medications StaveMD offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

SemaglutideTirzepatide

Pricing

Prices re-verified

Injection, month-to-month (4-week plan, billed every 4 weeks)Compounded
$149per 4 weeks
semaglutide

12 weeks $417, 24 weeks $774, 52 weeks $1,417 upfront (the "$109/mo" headline)

Oral dissolving tablet, month-to-month (4-week plan, billed every 4 weeks)Compounded
$199per 4 weeks
semaglutide

12 weeks $567, 24 weeks $1,074, 52 weeks $2,197 upfront (the "$169/mo" headline)

Injection, month-to-month (4-week plan, billed every 4 weeks)Compounded
$199per 4 weeks
tirzepatide

12 weeks $567, 24 weeks $1,074, 52 weeks $2,067 upfront (the "$159/mo" headline)

Microdose injection, month-to-month (4-week plan, billed every 4 weeks)Compounded
$179per 4 weeks
semaglutide

12 weeks $477, 24 weeks $894, 52 weeks $1,677 upfront (the "$129/mo" headline)

Microdose injection, month-to-month (4-week plan, billed every 4 weeks)Compounded
$179per 4 weeks
tirzepatide

Same ladder as semaglutide microdose: 12 weeks $477, 24 weeks $894, 52 weeks $1,677

Ready to get started?

Plans and promotions change often, so check StaveMD's current pricing and active discounts before you decide.

See StaveMD pricing →

What we like

  • Month-to-month semaglutide injections at $149 per 4 weeks, with no membership fee on top
  • Offers injections, a daily dissolving semaglutide tablet, and low-dose microdose programs for semaglutide or tirzepatide
  • Names its prescribing group (OpenLoop Healthcare Partners) and four fulfilling pharmacies, with addresses, in its terms
  • Cancel any time from your account, with no phone call and no notice period
  • Full refund if a provider decides treatment isn't right for you, since no medication is ordered
  • Free shipping, and the site says plans are HSA/FSA eligible

Watch-outs

  • The "from $109/mo" headline is the 52-week plan, charged as $1,417 upfront; month-to-month semaglutide is $149
  • Plans are labeled "/mo" but bill every 4 weeks, which is 13 charges a year, not 12
  • The full price list only appears after the whole health intake and your name, address, phone and email
  • "Trusted by millions" and "2,000,003+ members" are OpenLoop network totals, not StaveMD patients, per its own footer
  • The homepage says "LegitScript-certified," but no certification record exists for the site in LegitScript's directory
  • Refundability of unused months on a prepaid 12, 24 or 52-week plan is not spelled out
  • Support is email-only; no phone number is published

Is StaveMD worth it?

StaveMD is aimed squarely at people who want semaglutide, tirzepatide, an oral tablet or a microdose from one brand, billed monthly. It runs $149/month (per 4 weeks). That is a qualified figure, not a plain month-to-month price, so we don't rank it against the category median; the cost section below says what it covers. Its standout is a needle-free oral option for people who would rather not inject.

It offers a microdosing option and takes HSA/FSA payment.

How much StaveMD costs

Compounded semaglutide runs $149–$199/month depending on plan, the low end listed as “per 4 weeks”, and compounded tirzepatide runs $199/month (per 4 weeks).

Because StaveMD's headline figure is listed as “per 4 weeks”, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare StaveMD with the month-to-month prices of the alternatives below instead.

PlexusDx (about $149/month) is one of the closest alternatives to weigh StaveMD against.

Medications: what StaveMD prescribes

StaveMD prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.

StaveMD's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.

Who StaveMD is best for, and who should skip it

A good fit if you…

  • are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.

Look elsewhere if you…

  • specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
  • need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.

Trust, safety, and medical oversight

We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.

Bottom line

StaveMD is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. To see StaveMD against the wider field, use our ranking of semaglutide providers; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.

The Bottom Line

StaveMD scores highest on the strength of its clinical program: drug options and dosing support.

Score: 7.1/10Best for: people who want semaglutide, tirzepatide, an oral tablet or a microdose from one brand, billed monthlyFrom: $149/4 wks (billed per 4 weeks)

Ready to start with StaveMD?

From $149/4 wks (billed per 4 weeks). See current pricing and start your free consultation.

Visit StaveMD →

StaveMD might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If the lowest possible monthly price is your top priority, consider YourEra (from $89/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.
See all alternatives to StaveMD →

Head-to-head

Compare StaveMD vs…

StaveMD scores7.1/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

StaveMD is a telehealth brand that prescribes compounded semaglutide (injection or dissolving tablet), tirzepatide and low-dose microdose programs through OpenLoop's clinician network, with named compounding pharmacies and free shipping. Month-to-month plans start at $149 for semaglutide and $199 for tirzepatide. The "from $109/mo" headline is the 52-week plan, charged as $1,417 upfront. We scored it 7.1/10 across our six-dimension editorial framework.
StaveMD is an operating telehealth provider, and we found no FDA warning letter on file for it. We could not confirm a LegitScript certification or the name of the pharmacy that fills its prescriptions from its public pages. We last checked its prices and policies on its own site in September 2026. We scored it 7.1/10 from published information, which is not a clinical endorsement. Talk to a licensed clinician before starting any medication.
StaveMD starts at $149/month (per 4 weeks). See the pricing table above for every tier.
StaveMD doesn't use public promo or coupon codes. Third-party sites advertising "StaveMD discount codes" are typically fake; any current offer applies automatically through the link on this page.
StaveMD hasn't published its exact state footprint. Confirm coverage in your state before signing up.
StaveMD offers semaglutide (the active drug in Wegovy/Ozempic) and tirzepatide (the active drug in Zepbound/Mounjaro). These are dispensed as compounded formulations. A needle-free oral option is also available.
StaveMD dispenses compounded GLP-1s made by a licensed compounding pharmacy, with the same active ingredient as the brand drugs at a lower cash price. Compounded drugs are not FDA-approved as finished products; we cover what that means in the review.
StaveMD is a cash-pay program (no insurance required) and accepts FSA/HSA cards.
StaveMD's price includes medication, the clinician consult and shipping. See the "what's included" strip near the top of this review.
You complete an online intake, a licensed clinician looks at whether a GLP-1 fits your situation, and, if you're approved, your medication ships to your door. You can begin the consultation directly on StaveMD's site.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for StaveMD. The concerns our review flags: The "from $109/mo" headline is the 52-week plan, charged as $1,417 upfront; month-to-month semaglutide is $149; Plans are labeled "/mo" but bill every 4 weeks, which is 13 charges a year, not 12; The full price list only appears after the whole health intake and your name, address, phone and email; "Trusted by millions" and "2,000,003+ members" are OpenLoop network totals, not StaveMD patients, per its own footer. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this StaveMD review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See StaveMD's current pricing

Plans from $149/4 wks (billed per 4 weeks). Start your free consultation to check eligibility and today's price.

Visit StaveMD →